Global RNA-Based Vaccines Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 RNA-Based Vaccines Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China RNA-Based Vaccines Market Performance
• 2.3 USA RNA-Based Vaccines Market Performance
• 2.4 Europe RNA-Based Vaccines Market Performance
• 2.5 Japan RNA-Based Vaccines Market Performance
• 2.6 Korea RNA-Based Vaccines Market Performance
• 2.7 India RNA-Based Vaccines Market Performance
• 2.8 Southeast Asia RNA-Based Vaccines Market Performance
• 2.9 South America RNA-Based Vaccines Market Performance

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
• 3.2 China RNA-Based Vaccines Market Performance (Volume)
• 3.3 USA RNA-Based Vaccines Market Performance (Volume)
• 3.4 Europe RNA-Based Vaccines Market Performance (Volume)
• 3.5 Japan RNA-Based Vaccines Market Performance (Volume)
• 3.6 Korea RNA-Based Vaccines Market Performance (Volume)
• 3.7 India RNA-Based Vaccines Market Performance (Volume)
• 3.8 Southeast Asia RNA-Based Vaccines Market Performance (Volume)
• 3.9 South America RNA-Based Vaccines Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Pfizer
  • 4.1.1 Pfizer Profiles
  • 4.1.2 Pfizer Product Information
  • 4.1.3 Pfizer RNA-Based Vaccines Business Performance
  • 4.1.4 Pfizer RNA-Based Vaccines Business Development and Market Status
• 4.2 Roche
  • 4.2.1 Roche Profiles
  • 4.2.2 Roche Product Information
  • 4.2.3 Roche RNA-Based Vaccines Business Performance
  • 4.2.4 Roche RNA-Based Vaccines Business Development and Market Status
• 4.3 Sanofi-Aventis
  • 4.3.1 Sanofi-Aventis Profiles
  • 4.3.2 Sanofi-Aventis Product Information
  • 4.3.3 Sanofi-Aventis RNA-Based Vaccines Business Performance
  • 4.3.4 Sanofi-Aventis RNA-Based Vaccines Business Development and Market Status
• 4.4 Abbott Laboratories
  • 4.4.1 Abbott Laboratories Profiles
  • 4.4.2 Abbott Laboratories Product Information
  • 4.4.3 Abbott Laboratories RNA-Based Vaccines Business Performance
  • 4.4.4 Abbott Laboratories RNA-Based Vaccines Business Development and Market Status
• 4.5 Arrowhead Pharmaceuticals
  • 4.5.1 Arrowhead Pharmaceuticals Profiles
  • 4.5.2 Arrowhead Pharmaceuticals Product Information
  • 4.5.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Business Performance
  • 4.5.4 Arrowhead Pharmaceuticals RNA-Based Vaccines Business Development and Market Status
• 4.6 Benitec Biopharma
  • 4.6.1 Benitec Biopharma Profiles
  • 4.6.2 Benitec Biopharma Product Information
  • 4.6.3 Benitec Biopharma RNA-Based Vaccines Business Performance
  • 4.6.4 Benitec Biopharma RNA-Based Vaccines Business Development and Market Status
• 4.7 Calimmune Inc
  • 4.7.1 Calimmune Inc Profiles
  • 4.7.2 Calimmune Inc Product Information
  • 4.7.3 Calimmune Inc RNA-Based Vaccines Business Performance
  • 4.7.4 Calimmune Inc RNA-Based Vaccines Business Development and Market Status
• 4.8 Dicerna
  • 4.8.1 Dicerna Profiles
  • 4.8.2 Dicerna Product Information
  • 4.8.3 Dicerna RNA-Based Vaccines Business Performance
  • 4.8.4 Dicerna RNA-Based Vaccines Business Development and Market Status
• 4.9 Gradalis
  • 4.9.1 Gradalis Profiles
  • 4.9.2 Gradalis Product Information
  • 4.9.3 Gradalis RNA-Based Vaccines Business Performance
  • 4.9.4 Gradalis RNA-Based Vaccines Business Development and Market Status
• 4.10 Quark
  • 4.10.1 Quark Profiles
  • 4.10.2 Quark Product Information
  • 4.10.3 Quark RNA-Based Vaccines Business Performance
  • 4.10.4 Quark RNA-Based Vaccines Business Development and Market Status
• 4.11 RXi
• 4.12 Senesco
• 4.13 Sanofi-Aventis
• 4.14 Abbott Laboratories
• 4.15 Arrowhead Pharmaceuticals
• 4.20 Quark

5 Market Performance for Manufacturers

• 5.1 Global RNA-Based Vaccines Production (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global RNA-Based Vaccines Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global RNA-Based Vaccines Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global RNA-Based Vaccines Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Global RNA-Based Vaccines Market Performance (Production Point)

• 6.1 Global RNA-Based Vaccines Production (K Units) and Market Share by Regions 2013-2018
• 6.2 Global RNA-Based Vaccines Revenue (M USD) and Market Share by Regions 2013-2018
• 6.3 Global RNA-Based Vaccines Price (USD/Unit) by Regions 2013-2018
• 6.4 Global RNA-Based Vaccines Gross Margin by Regions 2013-2018

7 Development Trend for Regions (Production Point)

• 7.1 Global RNA-Based Vaccines Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
• 7.2 China RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.3 USA RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.4 Europe RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.5 Japan RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.6 Korea RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.7 India RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.8 Southeast Asia RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.9 South America RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

8 Global RNA-Based Vaccines Market Performance (Consumption Point)

• 8.1 Global RNA-Based Vaccines Consumption and Market Share by Regions 2013-2018
• 8.2 Global RNA-Based Vaccines Consumption Value and Market Share by Regions 2013-2018
• 8.3 Global RNA-Based Vaccines Price (USD/Unit) by Regions 2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global RNA-Based Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China RNA-Based Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA RNA-Based Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe RNA-Based Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan RNA-Based Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea RNA-Based Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India RNA-Based Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia RNA-Based Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America RNA-Based Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Cancer Industry
• 12.2 Diabetes Industry
• 12.3 Tuberculosis Industry
• 12.4 Cardiovascular Diseases Industry

13 Market Forecast 2019-2024

• 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global RNA-Based Vaccines Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 13.1.2 Global RNA-Based Vaccines Production (K Units) and Growth Rate 2019-2024
  • 13.1.3 China RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America RNA-Based Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.2 Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.1 Global RNA-Based Vaccines Consumption and Market Share by Regions 2019-2024
  • 13.2.2 Global RNA-Based Vaccines Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.3 China RNA-Based Vaccines Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.4 USA RNA-Based Vaccines Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.5 Europe RNA-Based Vaccines Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.6 Japan RNA-Based Vaccines Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.7 Korea RNA-Based Vaccines Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.8 India RNA-Based Vaccines Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.9 Southeast Asia RNA-Based Vaccines Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.10 South America RNA-Based Vaccines Sales, Sales Value and Growth Rate 2019-2024
• 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Type I Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 Type II Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Cancer Sales and and Growth Rate 2019-2024
  • 13.4.3 Diabetes Sales and and Growth Rate 2019-2024
  • 13.4.4 Tuberculosis Sales and and Growth Rate 2019-2024
  • 13.4.5 Cardiovascular Diseases Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global RNA-Based Vaccines Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global RNA-Based Vaccines Gross Profit Trend 2019-2024

14 Conclusion